94 related articles for article (PubMed ID: 31288238)
1. The Prognostic Value of the Pretreatment Neutrophil/Lymphocyte Ratio in Patients with Glioblastoma Multiforme Brain Tumors: A Retrospective Cohort Study of Patients Treated with Combined Modality Surgery, Radiation Therapy, and Temozolomide Chemotherapy.
Brenner A; Friger M; Geffen DB; Kaisman-Elbaz T; Lavrenkov K
Oncology; 2019; 97(5):255-263. PubMed ID: 31288238
[TBL] [Abstract][Full Text] [Related]
2. A Phase III study of radiation therapy (RT) and O⁶-benzylguanine + BCNU versus RT and BCNU alone and methylation status in newly diagnosed glioblastoma and gliosarcoma: Southwest Oncology Group (SWOG) study S0001.
Blumenthal DT; Rankin C; Stelzer KJ; Spence AM; Sloan AE; Moore DF; Padula GD; Schulman SB; Wade ML; Rushing EJ
Int J Clin Oncol; 2015 Aug; 20(4):650-8. PubMed ID: 25407559
[TBL] [Abstract][Full Text] [Related]
3. Outcomes and Treatment Algorithm in Glioblastoma Patients 80 Years and Older.
Fogg D; Gersey ZC; Pease M; Mallela AN; Andrews E; Plute T; Pearce TM; Njoku-Austin C; Anthony A; Amankulor NM; Zinn P
World Neurosurg; 2023 Oct; 178():e540-e548. PubMed ID: 37516146
[TBL] [Abstract][Full Text] [Related]
4. Glioblastoma in the elderly: treatment patterns and survival.
Pretanvil JA; Salinas IQ; Piccioni DE
CNS Oncol; 2017 Jan; 6(1):19-28. PubMed ID: 28001088
[TBL] [Abstract][Full Text] [Related]
5. Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM).
Gately L; Mesía C; Sepúlveda JM; Del Barco S; Pineda E; Gironés R; Fuster J; Dumas M; Gill S; Navarro LM; Herrero A; Dowling A; de Las Peñas R; Vaz MA; Alonso M; Lwin Z; Harrup R; Peralta S; Long A; Perez-Segura P; Ahern E; Garate CO; Wong M; Campbell R; Cuff K; Jennens R; Gallego O; Underhill C; Martinez-Garcia M; Covela M; Cooper A; Brown S; Rosenthal M; Torres J; Collins IM; Gibbs P; Balana C
J Neurooncol; 2024 Jun; 168(2):299-306. PubMed ID: 38630385
[TBL] [Abstract][Full Text] [Related]
6. Glioblastoma Recurrence Versus Treatment Effect in a Pathology-Documented Series.
Himes BT; Arnett AL; Merrell KW; Gates MJ; Bhargav AG; Raghunathan A; Brown DA; Burns TC; Parney IF
Can J Neurol Sci; 2020 Jul; 47(4):525-530. PubMed ID: 32077389
[TBL] [Abstract][Full Text] [Related]
7. Exploring the impact of primary care utilization and health information exchange upon treatment patterns and clinical outcomes of glioblastoma patients.
Parker M; Kazemi F; Ahmed AK; Kuo CC; Nair SK; Rincon-Torroella J; Jackson C; Gallia G; Bettegowda C; Weingart J; Brem H; Mukherjee D
J Neurooncol; 2024 Jun; 168(2):345-353. PubMed ID: 38662150
[TBL] [Abstract][Full Text] [Related]
8. White Matter Tract Density Index Prediction Model of Overall Survival in Glioblastoma.
Salvalaggio A; Pini L; Gaiola M; Velco A; Sansone G; Anglani M; Fekonja L; Chioffi F; Picht T; Thiebaut de Schotten M; Zagonel V; Lombardi G; D'Avella D; Corbetta M
JAMA Neurol; 2023 Nov; 80(11):1222-1231. PubMed ID: 37747720
[TBL] [Abstract][Full Text] [Related]
9. Association between giant cell glioblastoma and glioblastoma multiforme in the United States: A retrospective cohort study.
Bin Abdulrahman AK; Bin Abdulrahman KA; Bukhari YR; Faqihi AM; Ruiz JG
Brain Behav; 2019 Oct; 9(10):e01402. PubMed ID: 31464386
[TBL] [Abstract][Full Text] [Related]
10. Repeat resection for recurrent glioblastoma in the temozolomide era: a real-world multi-centre study.
Woo PYM; Law THP; Lee KKY; Chow JSW; Li LF; Lau SSN; Chan TKT; Ho JMK; Lee MWY; Chan DTM; Poon WS
Br J Neurosurg; 2023 Jan; ():1-9. PubMed ID: 36654527
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and Prognostic Value of Circulating DNA Fragments in Glioblastoma Multiforme Patients.
Jarmuzek P; Wawrzyniak-Gramacka E; Morawin B; Tylutka A; Zembron-Lacny A
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673808
[TBL] [Abstract][Full Text] [Related]
12. The need for geriatric scales in glioblastoma.
Domenech M; Hernandez A; Balana C
Aging (Albany NY); 2021 Jul; 13(14):17959-17960. PubMed ID: 34309582
[No Abstract] [Full Text] [Related]
13. Standards of care for treatment of recurrent glioblastoma--are we there yet?
Weller M; Cloughesy T; Perry JR; Wick W
Neuro Oncol; 2013 Jan; 15(1):4-27. PubMed ID: 23136223
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for preoperative and postoperative seizures in patients with glioblastoma according to the 2021 World Health Organization classification.
Feyissa AM; Sanchez-Boluarte SS; Moniz-Garcia D; Chaichana KL; Sherman WJ; Freund BE; Tatum WO; Middlebrooks EH; Sirven JI; Quinones-Hinojosa A
Seizure; 2023 Nov; 112():26-31. PubMed ID: 37729723
[TBL] [Abstract][Full Text] [Related]
15. Cytokine Profile in Development of Glioblastoma in Relation to Healthy Individuals.
Jarmuzek P; Defort P; Kot M; Wawrzyniak-Gramacka E; Morawin B; Zembron-Lacny A
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003396
[TBL] [Abstract][Full Text] [Related]
16. Management and outcomes of glioblastoma: 20-year experience in a single Australian institution.
Lenffer B; Ruben J; Senthi S; Millar J; Ong WL
J Med Imaging Radiat Oncol; 2024 Mar; 68(2):208-216. PubMed ID: 37997616
[TBL] [Abstract][Full Text] [Related]
17. Glioblastoma patients' survival and its relevant risk factors during the pre-COVID-19 and post-COVID-19 pandemic: real-world cohort study in the USA and China.
Qin L; Li H; Zheng D; Lin S; Ren X
Int J Surg; 2024 May; 110(5):2939-2949. PubMed ID: 38376848
[TBL] [Abstract][Full Text] [Related]
18. De Ritis ratio in elderly glioblastoma patients treated with chemoradiation: A comprehensive analysis of serum biomarkers.
Kim J; Lee HI; Kim IA; Lee JH; Cho J; Wee CW; Yoon HI
Neurooncol Adv; 2024; 6(1):vdad173. PubMed ID: 38288092
[TBL] [Abstract][Full Text] [Related]
19. Systematic review and pooled analysis of the impact of treatment-induced lymphopenia on survival of glioblastoma patients.
Saeed AM; Bentzen SM; Ahmad H; Pham L; Woodworth GF; Mishra MV
Radiat Oncol; 2024 Mar; 19(1):36. PubMed ID: 38481255
[TBL] [Abstract][Full Text] [Related]
20. The Equipoise Between the Treatment of Glioblastoma and the Risk of Secondary Acute Myelogenous Leukemia: An Illustrative Case Report.
Harari-Turquie M; Moturi KR; Horton DD; Rabinowitz I
J Investig Med High Impact Case Rep; 2023; 11():23247096231193266. PubMed ID: 37596951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
